Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
Status:
Completed
Trial end date:
2016-11-30
Target enrollment:
Participant gender:
Summary
This prospective randomized study elucidates the effects of exogenous nitric oxide delivered
to the extracorporeal circulation circuit for cardioprotection against ischemia-reperfusion
injury during coronary artery bypass graft surgery with cardiopulmonary bypass.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences